U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.326A>G (p.Glu109Gly) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 29, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002442923.3

Allele description [Variation Report for NM_000535.7(PMS2):c.326A>G (p.Glu109Gly)]

NM_000535.7(PMS2):c.326A>G (p.Glu109Gly)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.326A>G (p.Glu109Gly)
HGVS:
  • NC_000007.14:g.6003717T>C
  • NG_008466.1:g.10390A>G
  • NM_000535.7:c.326A>GMANE SELECT
  • NM_001322003.2:c.-80A>G
  • NM_001322004.2:c.-80A>G
  • NM_001322005.2:c.-80A>G
  • NM_001322006.2:c.326A>G
  • NM_001322007.2:c.35+255A>G
  • NM_001322008.2:c.35+255A>G
  • NM_001322009.2:c.-80A>G
  • NM_001322010.2:c.-80A>G
  • NM_001322011.2:c.-559A>G
  • NM_001322012.2:c.-559A>G
  • NM_001322013.2:c.-80A>G
  • NM_001322014.2:c.326A>G
  • NM_001322015.2:c.-159A>G
  • NP_000526.2:p.Glu109Gly
  • NP_001308935.1:p.Glu109Gly
  • NP_001308943.1:p.Glu109Gly
  • LRG_161t1:c.326A>G
  • LRG_161:g.10390A>G
  • NC_000007.13:g.6043348T>C
  • NM_000535.5:c.326A>G
  • NR_136154.1:n.413A>G
Protein change:
E109G
Links:
dbSNP: rs1785367984
NCBI 1000 Genomes Browser:
rs1785367984
Molecular consequence:
  • NM_001322003.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322004.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322005.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322009.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322010.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322011.2:c.-559A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-559A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322013.2:c.-80A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322015.2:c.-159A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322007.2:c.35+255A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.35+255A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000535.7:c.326A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322006.2:c.326A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322014.2:c.326A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136154.1:n.413A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002612399Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(May 29, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002612399.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.E109G variant (also known as c.326A>G), located in coding exon 4 of the PMS2 gene, results from an A to G substitution at nucleotide position 326. The glutamic acid at codon 109 is replaced by glycine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024